HRA Grant Consultation Program

The Medical School is offering the opportunity for investigators to work with Health Research Associates (HRA). HRA provides individual consultative services to advise investigators on preparing NIH proposals.

The goal of the HRA-GCP Program is to enhance the trajectory of tenure-track, tenured, and academic track faculty securing new NIH grants. The program is designed to support investigators who: 1) are applying for their first major R-series; or 2) have previously had NIH funding and have not secured additional NIH funding for at least two consecutive years and at least 1 submission.

2021 Program Requirements

Investigators who are accepted into the program must meet the following requirements:

  • Full commitment and participation in the program, including participation in: 1) the initial introductory meeting with Dr. Atherton and the other investigators in the program; 2) grant writing seminar with HRA; and 3) meet mutually developed expectations for meetings and follow up with Dr. Atherton during the proposal development.
  • Investigators must be the contact PI for a new NIH grant submission in NIH Cycle II and/or III during calendar year 2021.
  • Participation in follow-up discussions/surveys to assist with program evaluation.

**Space is still available** Applications must be submitted here. Eligibility criteria has been expanded to include all R01 applicants. Early-stage faculty will be given preference, and currently funded investigators may also apply for this program.View the Application Process listed below. Applications must be combined into a single PDF document for submission. 

  • Eligibility Requirements
  • Application Process
  • Selection Criteria & Considerations
  • Eligibility Requirements

    Program applicants must be a full-time, university paid, tenure-track, tenured, or academic track faculty member of the Medical School (must hold at least 51% primary appointment in the Medical School). **Update, 3/29/21** Eligibility criteria has been expanded to include all R01 applicants. Early-stage faculty will be given preference, and currently funded investigators may also apply for this program.

  • Application Process

    • Cover letter (2-page maximum): The applicant’s cover letter should address the following: 1) a description of how the applicant meets the programmatic goals and identified eligibility requirements; 2) a discussion of how this program fits into the applicant’s long-term research goals; 3) an affirmed commitment to fully participate in the program and utilize HRA’s services in 2021.
    • Applicant’s NIH biosketch
    • Three-year summary of NIH grant submissions in which the applicant was the contact PI (all NIH submissions should be included, one-page maximum): this information should be documented in table/spreadsheet form and include the following details (see example template): A) calendar year of grant submission; 2) grant series; 3) title of submission; 4) score; 5) if the grant was funded; and 6) name of any co-PIs.
    • Letter of recommendation from the department head: the letter of recommendation should highlight why the applicant should be selected for the program and how the program will specifically help the applicant develop over the next year.
  • Selection Criteria & Considerations

    Applicants must meet the eligibility requirements:

      • Full time, university paid, tenure-track, tenured, or academic track faculty member in the Medical School (with at least 51% primary appointment in the Medical School).
      • Faculty who have received an R01 grant (or similar) within the last two years are not eligible for the HRA program.
      • Be applying for their first major R-series or other NIH series grant or 2) have previously had NIH funding and have not secured additional NIH funding for at least two consecutive years and at least 1 submission.
      • Have identified specific aims and approaches.
      • Commit to fully participating in the program and utilizing HRA’s services in 2021.
      • Have a letter of recommendation from their department head.

    The following faculty will be prioritized:

      • Assistant professors who are poised to advance to associate professor.
      • Tenure-track faculty members. 
      • Faculty members who previously received NIH funding but no longer have an NIH grant. 

    Additional considerations will include:

      • Past NIH grant submissions (any series).
      • Demonstration that this program will assist the faculty member in securing new NIH funding.

    The review committee will consist of Vice Dean Ana Núñez, Vice Dean Timothy Schacker, and Associate Dean Amanda Termuhlen. The review committee will make recommendations to Dean Jakub Tolar. Notifications of acceptance will be sent out in early March.